We have provided evidence that HBx activates IKKβ, which leads to inactivation of TSC1 and activation of mTOR/S6K1 and to the production of angiogenesis factor VEGF-A in HBx expressing hepatoma cells and liver tissues of HBx transgenic mice. This evidence concerns the gene MTOR and hepatocellular carcinoma.